Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
Race against time: new Blood-Clotting treatment aims to stop trauma bleeding faster
Disease control Not yet recruitingThis study aims to see if a new, shelf-stable blood-clotting treatment (IFC) can be given faster than the standard treatment (Cryo-AHF) to people with severe bleeding after a traumatic injury. It will involve 320 adults arriving at trauma centers with life-threatening blood loss …
Sponsor: Cerus Corporation • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Scientists test safety of 'Cleaned' blood transfusions
Knowledge-focused Not yet recruitingThis study aims to understand the safety of a special type of processed red blood cells used in transfusions. Researchers will give small transfusions to people who either have or do not have antibodies against these processed cells. The main goal is to see if the transfusions tr…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Scientists track special blood cells in sickle cell patients
Knowledge-focused Not yet recruitingThis study aims to understand how long specially treated, pathogen-reduced red blood cells last in the body of adults with sickle cell disease. It will follow five patients who regularly receive blood exchange therapy, tracking the treated cells with special markers. The goal is …
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC